Article

Racial and Ethnic Reporting and Representation in Phase III Alzheimer’s Disease Clinical Trials in the US

2025-05-05

Abstract excerpt

<h4>Background</h4> Alzheimer’s disease (AD) disproportionately affects racial and ethnic minoritized populations in the United States, yet these groups remain markedly underrepresented in clinical research. Phase III clinical trials are critical for informing regulatory decision and treatment guidelines, but the extent to which they report and include racial and ethnic diverse participants in the US context has n...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dbc5f240-4890-5553-8a5f-c637951d692b
DOI: 10.1101/2025.05.03.25326933

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Racial and Ethnic Reporting and Representation in Phase III Alzheimer’s Disease Clinical Trials in the USDOI 10.1101/2025.05.03.25326933Read

A Systematic Review of Representation in Clinical Trials for Transthyretin Associated Cardiac Amyloidosis: Where Demographics Diverge from DiseaseSemantic proximity Read

Racial and Ethnic Diversity in Clinical Studies Reported to ClinicalTrials.gov, 2009-2024Semantic proximity Read

Current State and Demographic Trends of Medically Underserved Populations in Rare Disease Research in the United StatesSemantic proximity Read

Assessing non-white ethnic participation in type 2 diabetes mellitus randomized clinical trials: A Meta-AnalysisSemantic proximity Read

A FinnGen pilot clinical recall study for Alzheimer’s diseaseSemantic proximity Read

Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trialSemantic proximity Read

Adequate Underrepresented Minority Representation in Cancer Trials: Evidence from an NCI-Designated Center in a Minority CountySemantic proximity Read

The power of representation: Statistical analysis of diversity in US Alzheimer's disease genetics dataSemantic proximity Read

Demographic Diversity of Genetic Databases Used in Alzheimer’s Disease ResearchSemantic proximity Read

Algorithmic Fairness of Machine Learning Models for Alzheimer’s Disease Progression PredictionSemantic proximity Read

A Framework for Inclusive and Accessible Clinical Research in Rare DiseasesSemantic proximity Read

Race-Related Association between APOE Genotype and Alzheimer's Disease: A Systematic Review and Meta-Analysis.Semantic proximity Read